Medivation, Inc. (MDVN) Reports Q2 EPS Loss of $0.27, Revenues Fall Short
Tweet
Share
E-mailGet Alerts MDVN Hot Sheet
Price: $81.44 --0%
Financial Fact:
Collaboration revenue: 206.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Collaboration revenue: 206.17M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
Medivation, Inc. (NASDAQ: MDVN) reported Q2 EPS of ($0.27), $0.01 worse than the analyst estimate of ($0.26). Revenue for the quarter came in at $15.8 million versus the consensus estimate of $16.16 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ondas Holdings Inc. (ONDS) Misses Q2 EPS by 9c
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Candel Therapeutics, Inc. (CADL) Misses Q2 EPS by 29c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
